We are live on
!
Find out more
SA
Sovran Advisors Portfolio holdings
AUM
$1.34B
1-Year Est. Return
21.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.44%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$770M
AUM Growth
+$68.8M
(+9.8%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
16.87%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
481
New
73
Increased
256
Reduced
119
Closed
26
Avg Time Held
0.8
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$7.21M |
| 2 |
Apple
AAPL
|
+$6.33M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$5.14M |
| 4 |
Microsoft
MSFT
|
+$5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Dynamic Income Fund
PDI
|
+$2.67M |
| 2 |
Johnson & Johnson
JNJ
|
+$2.63M |
| 3 |
Celldex Therapeutics
CLDX
|
+$2.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.6M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.84% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 4.68% |
| 4 | Consumer Discretionary | 3.53% |
| 5 | Financials | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$897B
| $31.5M | 4.09% |
59,662
-4,406
| -7% | -$2.6M |
2024 Q4
1 quarter
|
|
2
iShares Core Universal USD Bond ETF
IUSB
$48.6B
| $19.4M | 2.52% |
426,686
+34,655
| +9% | +$1.58M |
2024 Q4
1 quarter
|
|
3
Innovator US Equity Ultra Buffer ETF September
USEP
$239M
| $18.5M | 2.4% |
554,660
+32,759
| +6% | +$1.16M |
2024 Q4
1 quarter
|
|
|
4
Apple
AAPL
$4.98T
| $15.9M | 2.06% |
80,572
+27,316
| +51% | +$6.33M |
2024 Q4
1 quarter
|
|
|
5
Microsoft
MSFT
$4.04T
| $13.5M | 1.75% |
36,610
+12,254
| +50% | +$5M |
2024 Q4
1 quarter
|
|
6
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $11.6M | 1.5% |
22,008
+726
| +3% | +$427K |
2024 Q4
1 quarter
|
|
7
iShares Bitcoin Trust
IBIT
$67B
| $11.1M | 1.45% |
230,923
+52,212
| +29% | +$2.76M |
2024 Q4
1 quarter
|
|
8
NVIDIA
NVDA
$5.52T
| $10.8M | 1.4% |
106,279
-643
| -0.6% | -$81.5K |
2024 Q4
1 quarter
|
|
9
iShares MSCI USA Quality Factor ETF
QUAL
$49B
| $10.7M | 1.39% |
66,272
+7,609
| +13% | +$1.36M |
2024 Q4
1 quarter
|
|
10
Invesco QQQ Trust
QQQ
$497B
| $9.91M | 1.29% |
22,325
+4,856
| +28% | +$2.47M |
2024 Q4
1 quarter
|
|
11
Capital Group Growth ETF
CGGR
$26.5B
| $9.8M | 1.27% |
301,671
+96,720
| +47% | +$3.62M |
2024 Q4
1 quarter
|
|
12
iShares 20+ Year Treasury Bond ETF
TLT
$48.7B
| $9.71M | 1.26% |
110,905
-4,034
| -4% | -$359K |
2024 Q4
1 quarter
|
|
13
BlackRock US Equity Factor Rotation ETF
DYNF
$42.7B
| $9.55M | 1.24% |
207,950
+10,981
| +6% | +$564K |
2024 Q4
1 quarter
|
|
14
iShares S&P 500 Growth ETF
IVW
$79.8B
| $9.53M | 1.24% |
107,698
+6,747
| +7% | +$680K |
2024 Q4
1 quarter
|
|
|
15
Ionis Pharmaceuticals
IONS
$7.04B
| $9.34M | 1.21% |
328,904
+157,092
| +91% | +$5.14M |
2024 Q4
1 quarter
|
|
16
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $9.27M | 1.2% |
183,519
-17,266
| -9% | -$872K |
2024 Q4
1 quarter
|
|
17
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.8B
| $9.13M | 1.19% |
99,683
+9,646
| +11% | +$883K |
2024 Q4
1 quarter
|
|
18
Innovator US Equity Ultra Buffer ETF December
UDEC
$244M
| $9.01M | 1.17% |
268,941
+12,414
| +5% | +$437K |
2024 Q4
1 quarter
|
|
19
iShares S&P 500 Value ETF
IVE
$49.5B
| $8.84M | 1.15% |
49,840
+14,803
| +42% | +$2.86M |
2024 Q4
1 quarter
|
|
20
SPDR Gold Trust
GLD
$141B
| $8.61M | 1.12% |
28,140
+1,092
| +4% | +$289K |
2024 Q4
1 quarter
|
|
21
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.07B
| $8.59M | 1.11% |
166,455
+17,192
| +12% | +$920K |
2024 Q4
1 quarter
|
|
22
iShares MSCI EAFE Value ETF
EFV
$30.4B
| $7.34M | 0.95% |
125,286
-15,903
| -11% | -$900K |
2024 Q4
1 quarter
|
|
23
Innovator Defined Wealth Shield ETF
BALT
$3.12B
| $7.21M | 0.94% |
232,792
+14,338
| +7% | +$453K |
2024 Q4
1 quarter
|
|
24
Amazon
AMZN
$2.79T
| $6.92M | 0.9% |
40,107
+7,122
| +22% | +$1.55M |
2024 Q4
1 quarter
|
|
25
Capital Group Dividend Value ETF
CGDV
$39.2B
| $6.77M | 0.88% |
202,074
+43,616
| +28% | +$1.58M |
2024 Q4
1 quarter
|
|
Similar funds
TIM
AFCM
ACM
DIP
CS
B
LIA
WTA
Sovran Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Sovran Advisors held 481 positions worth $770M, up 9.8% from $702M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Sovran Advisors deployed $130M of net new capital in Q1 2025, opening 73 new positions and adding to 256 existing holdings. Its largest new stake was Novo Nordisk: 36,559 shares worth $2.12M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Dynamic Income Fund, an estimated $2.67M trimmed.
- Sovran Advisors's largest Q1 2025 buy was Novo Nordisk: 36,559 shares worth $2.12M.
- Sovran Advisors added most to Qualcomm in Q1 2025, an estimated $7.21M increase.
- Sovran Advisors's biggest Q1 2025 reduction was PIMCO Dynamic Income Fund, cutting an estimated $2.67M.
- Sovran Advisors fully exited Celldex Therapeutics in Q1 2025, selling an estimated $2.6M.
- Sovran Advisors's ten largest holdings make up 20% of its $770M portfolio in Q1 2025.
- Sovran Advisors opened 73 new positions and closed 26 in Q1 2025.
- Sovran Advisors's portfolio value rose 9.8% quarter-over-quarter to $770M.
Based on Sovran Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.